James Xue
Chief Executive Officer at CANBRIDGE PHARMACEUTICALS INC.
Net worth: 2 M $ as of 31/05/2024
Profile
James Xue is the founder of CANbridge Life Sciences Ltd.
(founded in 2012) and CANbridge Pharmaceuticals Inc. (founded in 2018), where he holds the titles of Chairman, President & Chief Executive Officer and Chairman & Chief Executive Officer respectively.
Dr. Xue is also the founder of CANbridge Consulting LLC.
Dr. Xue's current job(s) include being the President, Secretary & Director at Canbridge Pharmaceuticals, Inc. (United States), Deputy Director General at China Alliance For Rare Diseases, Deputy Director at Shanghai Foundation For Rare Disease, Member-Leadership Council at Peking University Health Science Center, Member at The BayHelix Group, and Member-Leadership Council at the University of Michigan Medical School.
Dr. Xue's former job includes being the General Manager-Genzyme China at Genzyme Corp.Dr. Xue's education history includes a doctorate degree from Brown University (1997), a graduate degree from the University of California (1998), an MBA degree from the University of Virginia Darden School of Business (2002), and an undergraduate degree from Peking University School of Pharmaceutical Sciences (1992).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/06/2024 | 41,857,191 ( 9.85% ) | 2 M $ | 31/05/2024 |
James Xue active positions
| Companies | Position | Start |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Chief Executive Officer | 30/01/2018 |
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Chief Executive Officer | 12/06/2012 |
| CANbridge Consulting LLC | Founder | - |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | President | - |
| China Alliance For Rare Diseases | Corporate Officer/Principal | - |
| Shanghai Foundation For Rare Disease | Corporate Officer/Principal | - |
| University of Michigan Medical School | Corporate Officer/Principal | 01/08/2017 |
| Peking University Health Science Center | Corporate Officer/Principal | 01/08/2017 |
| The BayHelix Group | Corporate Officer/Principal | - |
Former positions of James Xue
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of James Xue
| Brown University | Doctorate Degree |
| University of California | Graduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
| Peking University School of Pharmaceutical Sciences | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Private companies | 7 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| The BayHelix Group | |
CANbridge Life Sciences Ltd.
CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Health Technology |
| CANbridge Consulting LLC | |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
| China Alliance For Rare Diseases | |
| Shanghai Foundation For Rare Disease |
- Stock Market
- Insiders
- James Xue
